Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception
International Journal of Molecular Sciences · 24.06.2026 · 27 (13) · 5678
DOI: 10.3390/ijms27135678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.06.2026. Verfasst von Leonardo Jacobsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brazilian Society for Research and Teaching in Medicine (SOBRAPEM), São Paulo 01318-901, Brazil. Hauptthemen laut MEDLINE: Endometriosis, Tirzepatide, Incretins, Nociception. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometriosis is increasingly recognized as a chronic systemic disorder extending beyond the classical estrogen-dependent paradigm, integrating metabolic, immune, fibrotic, and nociceptive pathways that sustain lesion persistence and refractory pelvic pain. We propose a mechanistic, translational hypothesis in which tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, may modulate four interconnected pathological axes of refractory endometriosis—Warburg-type metabolic reprogramming with lactate accumulation, peritoneal immune dysfunction, NF-κB/NLRP3/TGF-β1-driven inflammatory–fibrotic remodeling, and persistent nociceptive sensitization—through three convergent molecular nodes: AMPK-associated signaling, GLP-1 receptor activity in peritoneal macrophages and spinal microglia, and the NF-κB/NLRP3/TGF-β1 axis. Particular emphasis is placed on the concept of “peritoneal incretin deficiency”, characterized by reduced peritoneal GLP-1 concentrations and increased expression of incretin-degrading proteases. This concept currently rests on a single, non-replicated case–control study, and the broader mechanistic chain is supported largely by indirect evidence extrapolated from adjacent inflammatory, metabolic, and neuroimmune disease models rather than by endometriosis-specific data. Direct experimental or clinical validation in endometriosis-specific models is currently absent. Accordingly, this article represents a hypothesis-generating framework rather than evidence of established efficacy, or a clinical treatment recommendation, intended to guide future mechanistic and prospective clinical investigation of incretin-based modulation as a potential adjunctive strategy in refractory endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brazilian Society for Research and Teaching in Medicine (SOBRAPEM), São Paulo 01318-901, Brazil.
- Department of Gynecology, Escola Paulista de Medicina, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04024-002, Brazil.
- Brazilian Society of Personalized Medicine (SBMP), São Paulo 04552-050, Brazil.
ORCID-Profile: Leonardo Jacobsen, Diogo Pinto da Costa Viana, Adriana Luckow Invitti
Zitieren
APA
Jacobsen, L., Viana, D. P. D. C., Folador, G. M., Schor, E., & Invitti, A. L. (2026). Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception. International Journal of Molecular Sciences, 27(13), 5678. https://doi.org/10.3390/ijms27135678
Vancouver
Jacobsen L, Viana DPDC, Folador GM, Schor E, Invitti AL. Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception. International Journal of Molecular Sciences. 2026;27(13):5678. doi:10.3390/ijms27135678
BibTeX
@article{Jacobsen2026,
author = {Jacobsen, Leonardo and Viana, Diogo Pinto da Costa and Folador, Graciela Morgado and Schor, Eduardo and Invitti, Adriana Luckow},
title = {Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5678},
doi = {10.3390/ijms27135678}
}
EUVIMED